Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Dermato-Venereologica|January 27, 2022
Nonsense Suppression Therapy: An Emerging Treatment for Hereditary Skin DiseasesJiangfan Yu, Bingsi Tang, Xinglan He, et al.
Pharmacological Research|September 3, 2020
The aryl hydrocarbon receptor: An environmental effector in the pathogenesis of fibrosisYaqian Shi, Zhuotong Zeng, Jiangfan Yu, et al.
Clinical Rheumatology|June 3, 2021
Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysisXinyu Ma, Rui Tang, Mei Luo, et al.
Aesthetic Surgery Journal|April 9, 2024
The Price of Beauty: A Literature Review on Non-Tuberculous Mycobacteria Infection After Cosmetic ProceduresHao Ren, Yangfan Xiao, Bingsi Tang, et al.
Inflammopharmacology|July 10, 2023
Pyroptosis: the potential eye of the storm in adult-onset Still's diseaseXinglan He, Ruixuan You, Yaqian Shi, et al.
Life Sciences|April 13, 2024
m6A RNA methylation: The latent string-puller in fibrosisXinglan He, Bingsi Tang, Puyu Zou, et al.
International Immunopharmacology|March 16, 2020
Safety and efficacy of Rituximab in systemic sclerosis: A systematic review and meta-analysisRui Tang, Jiangfan Yu, Yaqian Shi, et al.
Frontiers in Immunology|November 17, 2022
Intimate intertwining of the pathogenesis of hypoxia and systemic sclerosis: A transcriptome integration analysisXinglan He, Yaqian Shi, Zhuotong Zeng, et al.
Oxidative Medicine and Cellular Longevity|December 31, 2019
Transcriptome Analysis and Emerging Driver Identification of CD8+ T Cells in Patients with VitiligoQiancheng Deng, Jingchao Wei, Puyu Zou, et al.
International Immunopharmacology|August 18, 2020
Aryl hydrocarbon receptor signaling activation in systemic sclerosis attenuates collagen production and is a potential antifibrotic targetYaqian Shi, Bingsi Tang, Jiangfan Yu, et al.
Pageof 2